F3 - coagulation factor III, tissue factor Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101082330
F3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_006934929.5 | XP_006934991.3 | tissue factor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tissue factor |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-104010 | Asciminib | Inhibitor | 99.61% | Yes |
| HY-104010A | Asciminib hydrochloride | Inhibitor | 99.84% | Yes |
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-157229 | STX-721 | Inhibitor | 98.25% | Phase 2 |
| HY-B2203 | Monocalcium glycerophosphate | Inhibitor | 98.0% | Phase 2 |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99271A | Tisotumab (powder) | / | Phase 3 | |
| HY-P991378 | MORAb-066 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(123)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-125845 | (S,R,S)-AHPC | 99.13% | Unkown | |
| HY-18960 | CHZ868 | Inhibitor | 98.69% | Unkown |
| HY-13491 | GNF-5837 | Inhibitor | 99.44% | Unkown |
| HY-130709 | PROTAC CDK2/9 Degrader-1 | Degrader | 99.85% | Unkown |
| HY-113437A | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate sodium | 98.0% | Unkown | |
| HY-11007 | GNF-2 | Inhibitor | 99.82% | Unkown |
| HY-125834 | GMB-475 | 98.69% | Unkown | |
| HY-134877 | BAY 2476568 | Inhibitor | 99.88% | Unkown |
| HY-N0600 | Ginsenoside F3 | 99.84% | Unkown | |
| HY-159147 | SIAIS039 | 99.68% | Unkown | |
| HY-131906 | JAK2-IN-7 | 98.31% | Unkown | |
| HY-E70134 | Endo-β-N-acetylglucosaminidase F3 | / | Unkown | |
| HY-126619 | Aspochalasin D | 95.0% | Unkown | |
| HY-162645 | BPR5K230 | Inhibitor | 99.82% | Unkown |
| HY-164397 | XMU-MP-5 | 99.00% | Unkown | |
| HY-18952A | (Z)-SU5614 | 98.09% | Unkown | |
| HY-133551 | WF-47-JS03 | Inhibitor | 99.63% | Unkown |
| HY-110026 | GTP-14564 | Inhibitor | 99.91% | Unkown |
| HY-12083 | PPY-A | Inhibitor | 98.02% | Unkown |
| HY-139997 | DDC-01-163 | Degrader | 99.05% | Unkown |
| HY-16983 | GNE-3500 | Antagonist | 98.90% | Unkown |
| HY-170820 | XYD049 | Inhibitor | 99.46% | Unkown |
| HY-174981 | LC-MF-4 | 98.05% | Unkown | |
| HY-RS03482 | CYP4F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W1048555A | Mal-PEG2000-SCM | 92.0% | Unkown | |
| HY-W081348 | 1-(4-Methoxyphenyl)-3-methyl-1H-pyrazol-5(4H)-one | Inhibitor | 99.54% | Unkown |
| HY-107662 | TCS PrP Inhibitor 13 | Inducer | 99.72% | Unkown |
| HY-113437 | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate | / | Unkown | |
| HY-151048 | JBJ-07-149 | Inhibitor | 99.09% | Unkown |
| HY-162940 | MerTK/Axl-IN-1 | Inhibitor | / | Unkown |
| HY-170928 | DA-0157 | Inhibitor | 99.59% | Unkown |
| HY-RS04112 | E2F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-113437AS | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate-d62 sodium | 99.0% | Unkown | |
| HY-N8448 | 3,4-Di-O-caffeoyl quinic acid methyl ester | Inhibitor | 98.77% | Unkown |
| HY-RS19322 | E2f3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W784556 | 5'-DMTr-dU(Allylamine-CO-F3)-3'-CE-phosphoramidite | / | Unkown | |
| HY-110402 | (S,R,S)-AHPC TFA | / | Unkown | |
| HY-136526 | BCR-ABL-IN-3 | Inhibitor | / | Unkown |
| HY-101763B | (S,R,S)-AHPC dihydrochloride | / | Unkown | |
| HY-112378 | D-65476 | Inhibitor | / | Unkown |
| HY-113777 | 22-HDHA | / | Unkown | |
| HY-116597 | L-783483 | Agonist | / | Unkown |
| HY-121888 | 20-HEPE | Agonist | / | Unkown |
| HY-126920 | AFG206 | / | Unkown | |
| HY-129764 | Prostaglandin F3α | Substrate | / | Unkown |
| HY-129764A | (17E)-Prostaglandin F3α | Control | / | Unkown |
| HY-131244 | ALK-IN-9 | Inhibitor | / | Unkown |
| HY-142922 | BCR-ABL-IN-4 | Inhibitor | / | Unkown |
| HY-144451 | TRK-IN-12 | Inhibitor | / | Unkown |
| HY-146807 | Type II TRK inhibitor 1 | Inhibitor | / | Unkown |
| HY-147813 | HIF-1α-IN-3 | Inhibitor | / | Unkown |
| HY-149965 | TRK-IN-23 | / | Unkown | |
| HY-154465 | 3’-F-3’-dG(iBu)-2’-phosphoramidite | / | Unkown | |
| HY-155302 | FLT3-IN-22 | Inhibitor | / | Unkown |
| HY-156086 | TRK-IN-24 | Inhibitor | / | Unkown |
| HY-156102 | c-ABL-IN-5 | / | Unkown | |
| HY-157432 | EGFR-IN-97 | / | Unkown | |
| HY-158313 | PROTAC EGFR degrader 13 | Inhibitor | / | Unkown |
| HY-158465 | GPEP FA2-KVANKT glycopeptide | / | Unkown | |
| HY-161269 | EGFR-IN-101 | Inhibitor | / | Unkown |
| HY-162881 | DS06652923 | Inhibitor | / | Unkown |
| HY-163004 | Type II TRK inhibitor 2 | Inhibitor | / | Unkown |
| HY-163366 | TRK-IN-28 | Inhibitor | / | Unkown |
| HY-170497 | EGFR-IN-140 | Inhibitor | / | Unkown |
| HY-170852 | QZ2135 | Degrader | / | Unkown |
| HY-170927 | JAK-IN-40 | / | Unkown | |
| HY-171884 | BI-8128 | Inhibitor | / | Unkown |
| HY-172478 | DSPE-PEG1000-F3 | / | Unkown | |
| HY-172479 | DSPE-PEG2000-F3 | / | Unkown | |
| HY-172479A | DSPE-PEG3400-F3 | / | Unkown | |
| HY-172480 | DSPE-PEG5000-F3 | / | Unkown | |
| HY-174330 | TRK-IN-31 | Inhibitor | / | Unkown |
| HY-174330A | TRK-IN-31 hydrochloride | Inhibitor | / | Unkown |
| HY-174415 | ZSH-2117 | / | Unkown | |
| HY-174437B | FLT3-IN-32 hydrochloride | / | Unkown | |
| HY-174974 | ISM7594 | Inhibitor | / | Unkown |
| HY-175302 | TRK-IN-32 | / | Unkown | |
| HY-175610 | PROTAC FLT3/JAK2/BRD4 Degrader-1 | Degrader | / | Unkown |
| HY-175864 | EGFR-IN-173 | Inhibitor | / | Unkown |
| HY-176259 | F3-PEG8-RiboTAC | / | Unkown | |
| HY-177030 | RNase L ligand 3 | / | Unkown | |
| HY-178057 | EGFR-IN-176 | / | Unkown | |
| HY-180172 | TRK-IN-33 | / | Unkown | |
| HY-180967 | PROTAC BCR-ABL Degrader-2 | / | Unkown | |
| HY-E70881 | Endoglycosidase F3 (D165A mutant) | / | Unkown | |
| HY-P10997 | F3 peptide | / | Unkown | |
| HY-R01574 | hsa-miR-518f-3p mimic | / | Unkown | |
| HY-R01574A | hsa-miR-518f-3p agomir | / | Unkown | |
| HY-R01603 | hsa-miR-520f-3p mimic | / | Unkown | |
| HY-R01603A | hsa-miR-520f-3p agomir | / | Unkown | |
| HY-R01683 | hsa-miR-548f-3p mimic | / | Unkown | |
| HY-R01683A | hsa-miR-548f-3p agomir | / | Unkown | |
| HY-R03051 | mmu-miR-344f-3p mimic | / | Unkown | |
| HY-R03051A | mmu-miR-344f-3p agomir | / | Unkown | |
| HY-R03176 | mmu-miR-466f-3p mimic | / | Unkown | |
| HY-R03176A | mmu-miR-466f-3p agomir | / | Unkown | |
| HY-R03467 | mmu-miR-669f-3p mimic | / | Unkown | |
| HY-R03467A | mmu-miR-669f-3p agomir | / | Unkown | |
| HY-RI01574 | hsa-miR-518f-3p inhibitor | / | Unkown | |
| HY-RI01574A | hsa-miR-518f-3p antagomir | / | Unkown | |
| HY-RI01603 | hsa-miR-520f-3p inhibitor | / | Unkown | |
| HY-RI01603A | hsa-miR-520f-3p antagomir | / | Unkown | |
| HY-RI01683 | hsa-miR-548f-3p inhibitor | / | Unkown | |
| HY-RI01683A | hsa-miR-548f-3p antagomir | / | Unkown | |
| HY-RI03051 | mmu-miR-344f-3p inhibitor | / | Unkown | |
| HY-RI03051A | mmu-miR-344f-3p antagomir | / | Unkown | |
| HY-RI03176 | mmu-miR-466f-3p inhibitor | / | Unkown | |
| HY-RI03176A | mmu-miR-466f-3p antagomir | / | Unkown | |
| HY-RI03467 | mmu-miR-669f-3p inhibitor | / | Unkown | |
| HY-RI03467A | mmu-miR-669f-3p antagomir | / | Unkown | |
| HY-RS02926 | CNTN1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04643 | F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10899 | POU2F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10902 | POU3F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10906 | POU4F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS13207 | SLC35F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-116008 | 8-iso Prostaglandin F3α | / | Unkown | |
| HY-154031 | 3'-F-3'-dA(Bz)-2'-Phosphoramidite | / | Unkown | |
| HY-177031 | RNA binder 3 | / | Unkown | |
| HY-RS16867 | F3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23308 | F3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23917 | Cntn1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25813 | E2f3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99271 | Tisotumab | 99.90% | Unkown | |
| HY-P990222 | Anti-Mouse/Rat IL-17A Antibody (17F3) | Inhibitor | 99.41% | Unkown |
| HY-P990212 | Anti-Mouse IL-6 Antibody (MP5-20F3) | Inhibitor | 99.36% | Unkown |
| HY-P990145 | Anti-Mouse VISTA Antibody (13F3) | Inhibitor | ≥95.0% | Unkown |
| HY-P992374 | huDMB5F3 | Inhibitor | / | Unkown |
| HY-P990411 | Anti-F3/Factor III/Tissue Factor/CD142 Antibody | Inhibitor | 98.88% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service